Disorders the use of intraoperative cell salvage in total hip arthroplasty with subtrochanteric shortening osteotomy for the treatment of high hip dislocation: retrospective cohort study

HIGHLIGHTS

• who: BMC Musculoskeletal et al. from the This study has been approved by the Clinical Trials and Biomedical Ethics Committee of West China Hospital, Sichuan University, and registered with the Chinese Clinical Trial Registry (ID: ChiCTR2200064064)Between November , and April, data on consecutive patients who were diagnosed with Type-III or IV DDH based on Crowe classification and underwent cementless THA combined with SSO in our institution were retrospectively collected in our institution. The exclusion criteria comprised patients who (1) underwent THA combined with SSO due to high hip dislocation secondary to pyogenic arthritis have published the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.